NEW-R Stock Overview
Engages in the hospital and medical trading businesses in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Wattana Karnpaet Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿97.00 |
| 52 Week High | ฿125.00 |
| 52 Week Low | ฿60.00 |
| Beta | 0.58 |
| 1 Month Change | 0% |
| 3 Month Change | -5.83% |
| 1 Year Change | -11.82% |
| 3 Year Change | 73.21% |
| 5 Year Change | 103.14% |
| Change since IPO | 1,210.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEW-R | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -1.2% |
| 1Y | -11.8% | -28.6% | -15.8% |
Return vs Industry: NEW-R exceeded the TH Healthcare industry which returned -28.6% over the past year.
Return vs Market: NEW-R exceeded the TH Market which returned -15.8% over the past year.
Price Volatility
| NEW-R volatility | |
|---|---|
| NEW-R Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in TH Market | 11.8% |
| 10% least volatile stocks in TH Market | 2.9% |
Stable Share Price: NEW-R's share price has been volatile over the past 3 months compared to the TH market.
Volatility Over Time: Insufficient data to determine NEW-R's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | n/a | n/a | www.wattanahospital.net |
Wattana Karnpaet Public Company Limited engages in the hospital and medical trading businesses in Thailand. The company operates a hospital under the North Eastern Wattana Hospital name and Nong Khai – Wattana Hospital, as well as Alliance International Medical Centre. It also operates clinics for various conditions and treatment, including dermatology; dentistry; general surgery; ear, nose, and throat; infectious disease; obstetrics and gynaecology; internal medicine; nephrology; vascular surgery; ophthalmology; orthopaedic surgery; pain; urology; pediatrics; health check up and wellness center; and Wattana home care and diabetes mellitus center.
Wattana Karnpaet Public Company Limited Fundamentals Summary
| NEW-R fundamental statistics | |
|---|---|
| Market cap | ฿970.00m |
| Earnings (TTM) | ฿39.59m |
| Revenue (TTM) | ฿455.79m |
24.5x
P/E Ratio2.1x
P/S RatioIs NEW-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEW-R income statement (TTM) | |
|---|---|
| Revenue | ฿455.79m |
| Cost of Revenue | ฿347.38m |
| Gross Profit | ฿108.41m |
| Other Expenses | ฿68.82m |
| Earnings | ฿39.59m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.96 |
| Gross Margin | 23.79% |
| Net Profit Margin | 8.69% |
| Debt/Equity Ratio | 0.3% |
How did NEW-R perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield45%
Payout RatioDoes NEW-R pay a reliable dividends?
See NEW-R dividend history and benchmarks| Wattana Karnpaet dividend dates | |
|---|---|
| Ex Dividend Date | May 09 2025 |
| Dividend Pay Date | May 20 2025 |
| Days until Ex dividend | 10 days |
| Days until Dividend pay date | 1 day |
Does NEW-R pay a reliable dividends?
See NEW-R dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 06:00 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wattana Karnpaet Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.